Amplification of Color Yield Obtained Using a Chromogenic Substrate for Determining Plasminogen Activator
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Amplification of Color Yield Obtained Using a Chromogenic Substrate for Determining Plasminogen Activator ; volume:38 ; number:02 ; year:1977
Konferenz: VIth International Congress on Thrombosis and Haemostasis; 1977-06-27
Thrombosis and haemostasis ; 38, Heft 02 (1977)
- Contributor
-
Friedmaa, Robert B.
Kwaan, Hau C.
Szczecinski, Marija
- DOI
-
10.1055/s-0039-1680382
- URN
-
urn:nbn:de:101:1-2019061208375863176272
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Friedmaa, Robert B.
- Kwaan, Hau C.
- Szczecinski, Marija
Other Objects (12)
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)